WBA $Walgreens Boots Alliance(WBA)$ good top line 3Q, but poor overall, lowers FY guidance
3Q YoY
Revenue +8.6%
Net Income -59%
Dil EPS -58% (Adj +3.3%)
first 9M
OCF -68%
FCF negative
FY23 guide
Adj EPS of $4.00 to $4.05 from $4.45 to $4.65 due to
"consumer & macroeconomic conditions"
A lot of WBA investment case is around the new (since FY22) U.S. Healthcare segment and how it can deliver profitability
Most acquisitions and investments (Shields, VillageMd, CareCentrix) are in this segment
It´s growing quicker, but burning more than guided.
Image
WBA this FY23 guidance slide (Oct vs June) tells the story
• US retail Pharmacy (80% of revenue)
growing faster
but margins eroding quicker
• International (15%)
Good improvement
• U.S. Healthcare (5%)
Growing 30% + guided
Burning 40%+ than guided
Image
WBA For now, the combined business is going lower than guided, so the confidence for the thereafter seems to have shaken "the markets"
Image
Comments